Top UFC Flyweight Contender Manon Fiorot Handed Three-Month Suspension Following Anti-Doping Policy Violation

Top women’s flyweight contender Manon Fiorot has been handed a three-month suspension after it was determined she violated the UFC’s anti-doping policy following an in-competition test stemming from her high-profile bout late last year. Promotion officials officially announced the news on Thursday, providing clarity on the status of one of the division’s most prominent figures as the new year unfolds.

Fiorot, the 36-year-old French standout with a professional mixed martial arts record of 13 victories and 3 defeats, was most recently seen inside the Octagon when she suffered a hard-fought loss to former women’s flyweight champion Alexa Grasso in September. That setback came on the heels of another major career milestone earlier in the year. Back in May of 2025 at UFC 315, which took place in Montreal, Fiorot dropped a unanimous decision against the reigning champion at the time, Valentina Shevchenko. That championship encounter stands as Fiorot’s lone UFC title shot to her name to date, marking the apex of her surge through the 125-pound weight class before running into the division’s elite tier.

The administrative action and subsequent suspension levied against the French fighter relate directly to an in-competition drug test administered in conjunction with the Grasso fight. During that testing window, Fiorot tested positive for ostarine, a substance that has increasingly drawn attention across various athletic disciplines. Originally developed as a therapeutic medication to help cancer patients rebuild muscle mass and combat muscle-wasting conditions, ostarine is classified as a selective androgen receptor modulator, commonly referred to as a SARM. Because of its anabolic properties and potential to enhance athletic performance and recovery, its use is strictly banned at all times under the comprehensive UFC anti-doping policy. The program is vigorously enforced by Combat Sports Anti-Doping, widely known as CSAD, with sample collection services managed professionally by Drug Free Sport.

In the wake of the initial finding, standard protocols and secondary assessments were initiated to determine the origin of the banned substance. Notably, an additional sample provided by Fiorot on October 19 successfully tested negative, following the initial positive test result that had been logged on September 12, 2026. This stark contrast between consecutive sample collections prompted a thorough and detailed investigation by regulatory and anti-doping personnel.

During the course of the CSAD investigation into Fiorot’s positive test result, her nutritionist was able to step forward and provide specific dietary supplements that had been given to the fighter leading up to the competition. In an effort to uncover the source of the ostarine, these nutritional products were sent for rigorous scientific evaluation by the Sports Medicine and Research Testing Laboratory, recognized as SMRTL, which serves as the official analytical laboratory for the UFC anti-doping program. The results of the laboratory analysis confirmed that two of the specific supplements provided by the nutritionist tested positive for ostarine contamination, pointing directly to an external source rather than a direct, conscious attempt by the athlete to cheat.

Because the investigation concluded that Fiorot’s exposure to the prohibited substance was entirely accidental and not the result of intentional use or deliberate doping, she successfully qualified for a reduced suspension under the established guidelines of the anti-doping program. However, regulatory authorities maintained that athletes still carry a fundamental duty of care regarding what they ingest. Because neither of the contaminated supplements had been independently tested or officially certified by a reputable third-party testing program prior to consumption, she still bore a degree of professional responsibility for the violation. Balancing these mitigating and aggravating factors, CSAD ultimately implemented a measured three-month ban rather than the maximum penalties typically reserved for intentional infractions.

With Fiorot’s provisional suspension having officially commenced on October 19, the date on which she was formally notified of the failed test from September, the timeline for her return to active competition has already been established. Having served the entirety of the mandated period, she will become fully eligible to return to action and resume her career on January 19, 2027.

As she prepares to put this administrative hurdle behind her and refocus on her athletic career, Manon Fiorot does not currently have a fight on the books, leaving fans and analysts to speculate on who she might face upon her return to the Octagon as she looks to work her way back toward another championship opportunity in the competitive women’s flyweight division.

More From Author

Nick Walker Gears Up for the Arnold Classic with a Brutal Heavy Upper-Body Workout

Leave a Reply

Your email address will not be published. Required fields are marked *